The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correction to Riggs and Hartmann, N Engl J Med 348(7):618-629 February 13, 2003.

Correction
PreviousPrevious
Volume 348:1192 March 20, 2003 Number 12

Selective Estrogen-Receptor Modulators — Mechanisms of Action and Application to Clinical Practice

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-Related Article
 by Riggs, B. L.
Selective Estrogen-Receptor Modulators — Mechanisms of Action and Application to Clinical Practice . There was an error in Figure 2; a corrected figure is shown here.

Figure Removed (Available Only in the Full Text)
View larger version (38K):
[in this window]
[in a new window]
 
Figure 2. Estrogen-Receptor Action.

Each class of SERMs (orange symbols) has a slightly different shape, although all will bind to the estrogen receptor. When it binds to an estrogen, antiestrogen, or SERM, the estrogen receptor undergoes a conformational change that permits its spontaneous dimerization and facilitates the subsequent interaction of the dimer with estrogen response elements (EREs) located within target genes. The estrogen-receptor–ligand complex also leads to binding of various coregulator proteins that vary with . . . [Full Text of this Article]

 



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.